• Coulter I. Antioxidants vitamin C and vitamin e for the prevention and treatment of cáncer. J Gen Int Med 21(7):735-44, Jul 2006
• Crawford E. The role of prostate-spécific antigen in the chemoprevention of prostate cáncer. J Cell Bioc Suppl 25:149-155, 1996
• Crawford E et al. Herbal and vitamin supplement use in a prostate cáncer screening population. Urology 63 (2):288-292,2004.
• Cross A et al. A prospective study of meat and meat mutagens and prostate cáncer risk. Cáncer Res. 65(24):11779-84 Dec 2005
• Cruz F. Mechanism involved in new therapies for overactive bladder. Urology 63(Suppl 3A): 65-73,2004.
• Cuellar D, Rhee J, Kyprianou N. Alpha1-adrenoceptor antagonists radiosensitize prostate cáncer cells via apoptosis induction.Anticáncer Res. 22(3):1673-1679, May 2002
• Cuendet M et al. The role of cyclooxygenase and lipoxygenase in cáncer chemoprevention. Drug Metab Drug Int 2000 17:109-57
• Cummings J, Bingham S. Fortnightly review: Diet and the prevention of cáncer. BMJ 317: 1636-1640, 1998
• Dalais F, Meliala A et al. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cáncer. Urology 64(3):510-515,Sep 2004.
• Dale W, Bilir P, Han M et al. The role of anxiety in prostate carcinoma. Cáncer 104(3):467-478, 2005
• Dalkin B, Lillico A, Reid M. Selenium and chemoprevention against prostate cáncer: An update on the Clark results. AACR Annual Meeting 42:460,2001 (abstr 2478)
• D'Amico A, Barry M. Prostate cáncer prevention and finasteride. J Urol. 176(5):2010-1012, Nov 2006
• Dalu A, Haskell J, Coward L. Genistein a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate 37(1):36-43, 1998
• Das S. Garlic. A Natural Source of Cáncer Preventive Compounds. Asían Pac J Cáncer Prev. 3(4):305-311, 2002
• Das P et al. The role of PC-SPES, selenium, and vitamin E in prostate cáncer. Oncology 16(3):285-291, March 2002
• Davidson D, Bostwick D, Qian J, et al. Prostatic Intraepithelial neoplasía is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 154,1295-1299 Oct 1995.
• Debruyne F, Koch G, Boyle P, et al. Comparison of a phytotherapeutic agent (Permixon®) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasía: a 1- year randomized international study. Eur Urol 2002; 41:497-507
• Debruyne F,Boyle P,Calais Da Silva F et al. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. Eur Urol. 45(6):773-779, Jun 2004
• Dedhia R et al. impact of Phytotherapy use on utility scores in patients with BPH/LUTS. J Urol 175(4) Suppl:529, April 2006
• DeLisa Joel. Physical Medicine and Rehabilitation. 2005. Lippincott. 2000 páginas
• Denis L, Morton M, Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol. 1999;35(5-6):377-87.
• De Marzo A. New concepts in tissue specifity for prostate cáncer and benign prostatic hyperplasía. Urol 53(3A)29-40,Mar 1999
• De Marzo, A, Nelson W, Isaacs W, Epstein J. Pathological and molecular aspects of prostate cáncer. Lancet, 361:955-64, 2003.
• De Marzo A, Meeker A, Epstein J, Coffey D. Prostate stem cell compartments: expresión of the cell cycle inhibitor p27 Kip 1 in normal, hyperplastic and neoplastic cells. Am J Pathol 153:911-919,1998
• De Marzo A, Marchi V, Epstein J, Nelson W. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155:1985-1992, 1999
• Demark-Wahnefried W et al. Pilot Study of dietary fat restriction and flaxseed supplementation in men with prostate cáncer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urol 58(1):47-52,2001.
• De Smet P. Herbal Remedies. N Eng J Med 347 (25) Dec 19, 2002
• De Vita V, Hellman S, Rosenberg S. Biologic Therapy of cáncer ed 2, Hagerstown Md, 1995, Lippincott-Raven
• Diamond S, Baccarini C, Brackin P. The effects of finasteride on hematuria and hematospermia after prostate needle biopsy. Journal Urology 165 (5): 262, 2001
• Di Máscio P. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Bioc Bioph 274(2):532-38, 1989
• Di Paola R. Clinical and biologic activity of an estrogenic herbal combinations(PC-SPES)in prostate cáncer.NEJM 339: 785,1998
• Di Silverio F, Monti S, Sciarra A et al. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasía. Prostate. 37(2):77-83, 1 Oct 1998
• Di Silverio F, D´Eramo G, Lubrano C et al. Evidence that Serenoa repens extract display an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 21:309-314, 1992
• Djavan B et al. Chemotherapeutic prevention studies of prostate cáncer. J Urol 171(2) part 2 of 2: S10-S14,2004.
• Djuric Z. Dietary modulation of oxidative DNA damage. Adv Exper Med Biol 354:71-83,1994
• Donovan J Jr et al. Immunotherapy of Prostate Cáncer. In Prob in Urol. Controv in Prost Canc Manag 4(3):482-505. Sep 1990.
• Doumerc N et al. Green Tea and prostate cáncer: a new sphingosine kinase inhibitor? Abs #581 Eur Urol Sup 5(2):168, 2006
• Dreikorn K. Complementary and Alternative Medicine in Urology. BJU Int 96:1177-1184, 2005
• Dreikorn K.Phytotherapeutic agents in the treatment of benign prostatic hyperplasía. Curr Urol Rep 1(2):103-109, Aug 2000
• Duffield-Lillico A, Dalkin B, Reid M and Nutritional Prevention of Cáncer Study Group et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cáncer: an analysis of the complete treatment period of the Nutritional Prevention of Cáncer Trial. BJU Int. 91(7):608-612. May 2003
• Duffield-Lillico A et al. Baseline characteristics and the effect of selenium supplementation on cáncer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cáncer Trial. Cáncer Epidemiology. Biom & Prevention 11(7):630–39 Jul 2002
• Dufour B, Choquenet C, Revol M, Faure G, Jorest R.Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma. Ann Urol (Paris) 18(3):193-195, May 1984
• Duke R, Ojcius D, Young J. Cell Suicide in Health and Disease. Scienti American. 275(6), 80-87 Dec 1996
• Dutton J. Use of an automated telephone counsellor to reduce serum lipids in hypercholesterolemia. J Gen Int Med 1995;10:99
• Eicholzer M, Stahelin H, Gey K. Prediction of male cáncer mortality by plasma levels of interacting vitamins: 17 year follow up of the prospective Basel study. Int J Cáncer 66:145-150,1996
• Eisenberg D. Trends in Alternative Medicine use in the United States 1990-1997. Results of a Follow-up National Survey JAMA 280(18):1569-1570,1998
• Eisenberg D et al. Unconventional Medicine in the United States. New England Journal of Medicine 328:246-52, 1993
• Eisenberg D, Davis R, Ettner S et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (18): 1569-1575, 1998.
• Ellis L, Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57(2): 72-75, 1992.
• Emmert B et al. Allelic loss on chromosome 8:12-21 in microdissected prostatic intraepithelial neoplasía. Canc Res. 55(14):2959-2962, Jul 1995
• Epstein J, Grignon D, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasía. Am J Surg Pathol. 19(8): 873-86 Aug 1995.
• Ernst E, Resch K, Mills S. Complementary medicine a definition. Br J Gen Pract 45:506, 1995
• Ernst E et al. The prevalence of complementary/alternative medicine in cáncer: a systematic review. Cáncer 83:777-782, 1998
• Esmat A, Refaie F, Shaheen M, et al Chemoprevention of prostate carcinogenesis by DFMO and/or finasteride treatment in male Wistar rats. Tumori. 88(6):513-521, Nov-Dec 2002
• Etzioni R, Howlader N, Shaw P et al. Long-Term effects of Finasteride on prostate specific antigen levels: results from the prostate cáncer prevention trial. J Urol 174,877-881, Sep 2005
• Evans B, Griffiths K, Morton M. Inhibition of 5-alpha reductase in genital skin fibroblast and prostate tissue by dietary lignans and isoflavonoids J Endocrinol 147(2):295-302, 1995
• European Prospective Investigation into Cáncer and Nutrition (EPIC) WHO-IARC Europe Against Cáncer - European Commission EPIC http://www. iarc.fr/ epic/
• Fair W, Fleshner N, Heston W. Cáncer of the Prostate a nutritional disease? Urology 50:840-848,1997
• Fagelman E, Lowe F. Herbal medications in the treatment of benign prostatic hyperplasía. Urology 55:533,2000.
• Fagelman E et al. Herbal medications in the treatment of benign prostatic hyperplasía. Urol Clin North Am. 29(1):23-29.Feb 2002
• Fair W, Fleshner N, Heston W. Cáncer of the Prostate a nutritional disease? Urology 50:840,1997
• Fantl J, Bump R, Robinson D et al. Efficacy of strogens supplementation in the treatment of urinary incontinence: the Continence Program for Women Research Group. Obstet Gynecol 88:745-749,1996
• Fawzy F. Malignant melanoma. Effects of an early structured psychiatric intervention coping, and effective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50(9):681-689,1993
• Feifer A et al. Analytical Accuracy and Reliability of Commonly Used Nutritional Supplements in Prostate Disease. J Urol 168(1):150-54, 2002
• Ferguson J, Zincke H, Ellison E, et al. Decreased of prostatic intraepithelialneoplasía following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy Urology 44(1): 91-5 Jul 1994
• Fernandez E, Gallus S, La Vecchia C.Nutrition and cáncer risk: an overview. J Br Menopause Soc. 12(4):139-142, Dec 2006
• Ferruelo A, Angulo J et al. Modification of proliferation, apoptosis and androgen receptor expression of LNCAP cells by diet polyphenols. Abstract # 582. Eur Urol Suppl 5(2):168, 2006
• Fingerhut M et al. Cáncer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. NEJM 324(4): 212-218, 1991.
• Flagg E, Coates R, Greenberg R. Epidemiologic studies of antioxidants and cáncer in humans. J Am Coll Nutr . 14:419-427, 1995
• Fleshner N, Kucuc O. Antioxidant dietary supplemnets: rationale and current status as chemopreventive agents for prostate cáncer. Urology 57(4A) 90-94,April 2001